Active

Wechelpharma

Switched

BE0885230908

Rechtspersoon Private limited company 1 establishment

Gebroeders De Winterstraat 32, 2275 Lille Activiteiten van holdings

Active for

19 year, 9 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 164,612

▼ 1% vs 2024

Profit

Growing

€ 653,281

▲ 319% vs 2024

Debts

Low

€ 630,450

▼ 37% vs 2024

Wechelpharma from Lille, company number BE0885230908, closed financial year 2025 with a result of € 653,281 after tax. For that financial year Wechelpharma recorded a gross margin of € 164,612 and equity of € 1.9 million. Compared with financial year 2024, the result moved from € 155,814 to € 653,281. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 23, 2026.

What happened at Wechelpharma?

What happened at Wechelpharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 653,281 (▲ 319% vs 2024). Source: NBB ↗
  • New establishment in Lille. KBO
  • Jeroen Peeters became a director. NBB
  • Brigitte Dekeyser became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 196,970 profit in 2021 to € 653,281 profit in 2025.

Paid € 268,785 in corporate taxes since 2021.

Best year ever: 2025, with € 653,281 profit.

Paid out € 649,286 in dividends to the owners in total.

A new publication or filing at Wechelpharma? We notify you, reason included.

Follow Wechelpharma

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Jeroen Peeters
Brigitte Dekeyser
Wechelpharma

Behind Wechelpharma are Jeroen Peeters and Brigitte Dekeyser. It owns 99.7% of Apotheek Peeters-Dekeyser itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Jeroen Peeters

Bestuurder

Also active at: Apotheek Peeters-Dekeyser

since 2006

Brigitte Dekeyser

Bestuurder

since 2006

Establishments

Establishment units

Physical locations of this company

Registered office

Gebroeders De Winterstraat 32

2275 Lille

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0885.230.908
VAT number
BE 0885.230.908
Registered office
Gebroeders De Winterstraat 32, 2275 Lille
Names & denominations
Wechelpharma
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
24 November 2006
Peppol
Active · Active since 24 Nov 2023
Activities · NACE

Activiteiten van holdings

Managementactiviteiten van holdings

Holdings

Frequently asked questions

What is the enterprise number of Wechelpharma?
The enterprise number of Wechelpharma is BE0885230908.
What is the address of Wechelpharma?
The registered office of Wechelpharma is located at Gebroeders De Winterstraat 32, 2275 Lille.
When was Wechelpharma founded?
Wechelpharma was founded on 24 November 2006.
What is the main activity of Wechelpharma?
The main activity of Wechelpharma is "Activiteiten van holdings" (NACE code 64210).
Does Wechelpharma have a website?
No website is currently known for Wechelpharma.
How much profit did Wechelpharma make in 2025?
Wechelpharma posted a profit after taxes of € 653,281 in financial year 2025.
What is the revenue of Wechelpharma?
As a small company, Wechelpharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 164,612.
Where can I find the annual accounts of Wechelpharma?
Wechelpharma files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Wechelpharma?
According to the 2025 annual accounts, the directors of Wechelpharma are: Jeroen Peeters, Brigitte Dekeyser.
Who owns Wechelpharma?
Behind Wechelpharma are Jeroen Peeters and Brigitte Dekeyser. It owns 99.7% of Apotheek Peeters-Dekeyser itself.